ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells

Osteosarcoma is the most common malignant bone neoplasia occurring in young patients in the first two decades of life, and represents 20% of all primitive malignant bone tumours. At present, treatment of metastatic osteosarcoma is unsatisfactory. High-dose chemotherapy followed by CD34+ leukapheresi...

Descripción completa

Detalles Bibliográficos
Autores principales: Valabrega, G, Fagioli, F, Corso, S, Madon, E, Brach del Prever, A, Biasin, E, Linari, A, Aglietta, M, Giordano, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747549/
https://www.ncbi.nlm.nih.gov/pubmed/12569382
http://dx.doi.org/10.1038/sj.bjc.6600735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747549/
https://www.ncbi.nlm.nih.gov/pubmed/12569382
http://dx.doi.org/10.1038/sj.bjc.6600735

Ejemplares similares